Text Messaging Adherence to Stimulant Medication
NCT01967485 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2017-02-23
Summary
The purpose of this study is to determine if an individualized text messaging intervention for the parents of children with Attention Deficit/Hyperactivity Disorder is effective in improving medication adherence and disease management.
Conditions
- Attention Deficit Hyperactivity Disorder
Interventions
- OTHER
-
Text- Messaging
Text messages will be sent to the parents of children enrolled in the study.
- OTHER
-
Treatment as usual
Children will receive stimulant treatment for ADHD.
Sponsors & Collaborators
-
American Academy of Child Adolescent Psychiatry.
collaborator OTHER -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Mai Uchida, MD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2016-08-31
- Completion
- 2016-09-30
Countries
- United States
Study Locations
More Related Trials
-
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
NCT00466791 ·Status: COMPLETED ·Phase: PHASE2
-
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
NCT00301236 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00956605 ·Status: COMPLETED ·Phase: NA
-
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
NCT00586157 ·Status: COMPLETED ·Phase: PHASE4
-
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
NCT00824317 ·Status: COMPLETED ·Phase: NA
-
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
NCT00179894 ·Status: COMPLETED ·Phase: NA
-
Multisite Study of High School-based Treatment for Adolescents With ADHD
NCT04480346 ·Status: COMPLETED ·Phase: NA
-
Methylphenidate for Treating Children With ADHD and Tourette Syndrome
NCT00441649 ·Status: COMPLETED ·Phase: NA
-
Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder
NCT00947973 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
NCT05286762 ·Status: COMPLETED ·Phase: PHASE3
-
New Technologies to Help Manage ADHD
NCT02390791 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
NCT02734693 ·Status: COMPLETED ·Phase: PHASE3
-
Primary Care Prevention of Stimulant Diversion by High School Students With ADHD
NCT03080259 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
NCT00499863 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
NCT00151983 ·Status: COMPLETED ·Phase: PHASE3
-
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
NCT00000388 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
NCT00501293 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
NCT02096952 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder
NCT06375525 ·Status: COMPLETED ·Phase: NA
-
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
NCT00178503 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
NCT01239030 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Mobile Neurofeedback for ADHD Youth
NCT04469335 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type
NCT00834821 ·Status: COMPLETED ·Phase: NA
-
Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)
NCT03363568 ·Status: COMPLETED ·Phase: NA